Hypertension Trial, Recruiting (NCT06933836)

Hypertension Trial, Recruiting NCT06933836 Sponsor: Barnet Dulaney Perkins Eye Centers Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06933836 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a type of glaucoma called primary open angle glaucoma (POAG)
You are 30 years of age or older
Your eye pressure (the fluid pressure inside your eye) is between 18 and 26 mmHg
Your glaucoma is considered mild or moderate (not advanced)
You are scheduled to receive or are being considered for a specific laser treatment called DSLT (Deep Sclerotherapy Laser Treatment) (confirm with trial site)

Who may not be able to join:

You have previously received any treatment for glaucoma, including eye drops, laser procedures, or eye surgery (in either eye)
Your glaucoma is a type where the drainage angle in your eye is closed or narrow, rather than open
You have been diagnosed with high eye pressure without glaucoma (ocular hypertension)
Your vision field test results show significant vision loss beyond a certain level (-12dB) (confirm with trial site)
You have an uncontrolled health condition affecting your blood vessels, such as high blood pressure or diabetes
You have certain physical findings around the coloured part of your eye, such as unusual pigmentation, growths, or tissue overgrowth on the eye's surface (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christine Funke, Medical Doctor, Barnet Dulaney Perkins Eye Centers

Phone: 4804201005

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06933836

Sponsor: Barnet Dulaney Perkins Eye Centers

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: 4804201005

More information: https://clinicaltrials.gov/study/NCT06933836

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a type of glaucoma called primary open angle glaucoma (POAG)
You are 30 years of age or older
Your eye pressure (the fluid pressure inside your eye) is between 18 and 26 mmHg
Your glaucoma is considered mild or moderate (not advanced)
You are scheduled to receive or are being considered for a specific laser treatment called DSLT (Deep Sclerotherapy Laser Treatment) (confirm with trial site)

Who may not be able to join:

You have previously received any treatment for glaucoma, including eye drops, laser procedures, or eye surgery (in either eye)
Your glaucoma is a type where the drainage angle in your eye is closed or narrow, rather than open
You have been diagnosed with high eye pressure without glaucoma (ocular hypertension)
Your vision field test results show significant vision loss beyond a certain level (-12dB) (confirm with trial site)
You have an uncontrolled health condition affecting your blood vessels, such as high blood pressure or diabetes
You have certain physical findings around the coloured part of your eye, such as unusual pigmentation, growths, or tissue overgrowth on the eye's surface (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Barnet Dulaney Perkins Eye Centers

Registry

ClinicalTrials.gov

Start date

31 March 2025

Est. completion

30 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Success of IOP Reduction Through DSLT Utilization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov